Stock listing
Lang & Schwarz:A2PCBU INmune Bio Inc. Aktie
German listing (Lang & Schwarz) of INmune Bio Inc. · home listing NASDAQ:INMB
Follow INmune Bio Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:INMB
$1.45 USD -0.15 (-9.4%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:INMB
- Day range
- $1.43 – $1.56 USDOct 30, 2026
- Volume
- 184,099 sharesOct 30, 2026
- Market cap
- $40.24M USDAt the close on Oct 30, 2026 · price × 27.75M shares outstanding
- 52-week range
- $1.09 – $2.60 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $665,404 USDMedian day 271,014 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:INMB · Home | $1.45 USD | -0.15 (-9.4%) | 184,099 | $1.53 | $1.555 | $1.43 | $1.60 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:INMB · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.45 | -0.15 | -9.4% | $1.53 | $1.555 | $1.43 | 184,099 | |
| $1.60 | +0.07 | +4.6% | $1.53 | $1.65 | $1.53 | 185,886 | |
| $1.53 | +0.01 | +0.7% | $1.50 | $1.53 | $1.46 | 188,536 | |
| $1.52 | +0.09 | +6.3% | $1.41 | $1.53 | $1.40 | 274,777 | |
| $1.43 | -0.03 | -2.1% | $1.47 | $1.49 | $1.41 | 162,787 | |
| $1.46 | -0.08 | -5.2% | $1.53 | $1.53 | $1.45 | 190,563 | |
| $1.54 | -0.07 | -4.3% | $1.58 | $1.63 | $1.52 | 220,703 | |
| $1.61 | +0.01 | +0.6% | $1.61 | $1.69 | $1.60 | 229,971 | |
| $1.60 | +0.06 | +3.9% | $1.53 | $1.63 | $1.53 | 75,599 | |
| $1.54 | -0.03 | -1.9% | $1.58 | $1.58 | $1.51 | 156,577 | |
| $1.57 | -0.08 | -4.8% | $1.68 | $1.68 | $1.56 | 196,169 | |
| $1.65 | +0.05 | +3.1% | $1.60 | $1.68 | $1.53 | 628,019 | |
| $1.60 | -0.08 | -4.8% | $1.70 | $1.915 | $1.59 | 1,136,971 | |
| $1.68 | -0.10 | -5.6% | $1.77 | $1.79 | $1.64 | 247,264 | |
| $1.78 | -0.11 | -5.8% | $1.89 | $1.89 | $1.78 | 72,743 | |
| $1.89 | +0.06 | +3.3% | $1.84 | $1.91 | $1.84 | 91,631 | |
| $1.83 | -0.03 | -1.6% | $1.85 | $1.87 | $1.79 | 379,165 | |
| $1.86 | -0.01 | -0.5% | $1.82 | $1.88 | $1.82 | 104,377 | |
| $1.87 | -0.07 | -3.6% | $1.95 | $1.978 | $1.82 | 311,074 | |
| $1.94 | +0.01 | +0.5% | $1.90 | $1.97 | $1.88 | 267,250 | |
| $1.93 | 0.00 | 0.0% | $1.97 | $1.999 | $1.93 | 290,237 | |
| $1.93 | -0.02 | -1.0% | $1.96 | $1.97 | $1.88 | 340,814 | |
| $1.95 | -0.01 | -0.5% | $1.98 | $2.02 | $1.94 | 201,903 | |
| $1.96 | -0.04 | -2.0% | $2.01 | $2.02 | $1.94 | 286,553 | |
| $2.00 | -0.03 | -1.5% | $2.02 | $2.045 | $1.94 | 191,597 | |
| $2.03 | +0.03 | +1.5% | $2.01 | $2.04 | $1.96 | 196,171 | |
| $2.00 | 0.00 | 0.0% | $2.00 | $2.01 | $1.94 | 167,874 | |
| $2.00 | -0.16 | -7.4% | $2.15 | $2.175 | $1.99 | 487,603 | |
| $2.16 | -0.13 | -5.7% | $2.31 | $2.36 | $2.16 | 375,456 | |
| $2.29 | -0.04 | -1.7% | $2.35 | $2.42 | $2.29 | 306,667 | |
| $2.33 | +0.15 | +6.9% | $2.22 | $2.398 | $2.213 | 677,640 | |
| $2.18 | +0.13 | +6.3% | $2.065 | $2.215 | $2.06 | 421,665 | |
| $2.05 | -0.21 | -9.3% | $2.22 | $2.238 | $1.965 | 923,287 | |
| $2.26 | -0.07 | -3.0% | $2.35 | $2.35 | $2.21 | 350,252 | |
| $2.33 | +0.11 | +5.0% | $2.23 | $2.35 | $2.18 | 370,102 | |
| $2.22 | -0.09 | -3.9% | $2.35 | $2.37 | $2.21 | 228,375 | |
| $2.31 | -0.15 | -6.1% | $2.43 | $2.46 | $2.29 | 385,850 | |
| $2.46 | -0.05 | -2.0% | $2.545 | $2.575 | $2.45 | 239,842 | |
| $2.51 | +0.07 | +2.9% | $2.44 | $2.60 | $2.41 | 494,310 | |
| $2.44 | +0.17 | +7.5% | $2.27 | $2.45 | $2.22 | 323,961 | |
| $2.27 | -0.08 | -3.4% | $2.37 | $2.409 | $2.27 | 149,805 | |
| $2.35 | +0.11 | +4.9% | $2.25 | $2.38 | $2.245 | 171,014 | |
| $2.24 | -0.06 | -2.6% | $2.26 | $2.27 | $2.213 | 206,153 | |
| $2.30 | -0.03 | -1.3% | $2.32 | $2.33 | $2.21 | 295,260 | |
| $2.33 | -0.07 | -2.9% | $2.40 | $2.45 | $2.301 | 215,132 | |
| $2.40 | -0.045 | -1.8% | $2.47 | $2.49 | $2.40 | 323,505 | |
| $2.445 | +0.015 | +0.6% | $2.40 | $2.499 | $2.40 | 419,652 | |
| $2.43 | +0.07 | +3.0% | $2.40 | $2.44 | $2.35 | 264,804 | |
| $2.36 | +0.04 | +1.7% | $2.30 | $2.48 | $2.24 | 501,661 | |
| $2.32 | +0.16 | +7.4% | $2.22 | $2.341 | $2.19 | 520,144 | |
| $2.16 | -0.07 | -3.1% | $2.20 | $2.24 | $2.145 | 393,670 | |
| $2.23 | +0.12 | +5.7% | $2.17 | $2.27 | $2.13 | 437,072 | |
| $2.11 | -0.02 | -0.9% | $2.09 | $2.18 | $2.08 | 231,193 | |
| $2.13 | -0.04 | -1.8% | $2.17 | $2.195 | $2.105 | 257,528 | |
| $2.17 | +0.09 | +4.3% | $2.09 | $2.20 | $2.04 | 462,033 | |
| $2.08 | +0.04 | +2.0% | $2.05 | $2.125 | $2.03 | 208,581 | |
| $2.04 | -0.04 | -1.9% | $2.08 | $2.106 | $2.01 | 352,100 | |
| $2.08 | -0.04 | -1.9% | $2.06 | $2.12 | $2.01 | 436,625 | |
| $2.12 | +0.035 | +1.7% | $2.10 | $2.195 | $2.05 | 462,842 | |
| $2.085 | +0.175 | +9.2% | $1.97 | $2.105 | $1.92 | 953,027 | |
| $1.91 | +0.01 | +0.5% | $1.86 | $1.94 | $1.84 | 244,596 | |
| $1.90 | -0.01 | -0.5% | $1.95 | $1.96 | $1.79 | 491,223 | |
| $1.91 | +0.06 | +3.2% | $1.88 | $1.95 | $1.855 | 414,336 | |
| $1.85 | +0.10 | +5.7% | $1.77 | $1.87 | $1.72 | 222,895 | |
| $1.75 | -0.02 | -1.1% | $1.77 | $1.79 | $1.715 | 225,756 | |
| $1.77 | +0.08 | +4.7% | $1.70 | $1.78 | $1.69 | 134,240 |
- Ticker
- Lang & Schwarz:A2PCBU
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Oct 28, 2026
INmune Bio, Inc. Announces Pricing of $4.50 Million Registered Direct Offering and Concurrent Private Placement
Latest earnings call · Aug 6, 2026
Inmune Bio (NASDAQ:INMB) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Oct 21, 2026
Investor Presentation (October 2026)
Investor deck · 53 slides
Calls
Upcoming
Inmune Bio (NASDAQ:INMB) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 4:30 PM ET
Register
Replays
Inmune Bio (NASDAQ:INMB) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 4:30 PM ET
Watch TranscriptInmune Bio (NASDAQ:INMB) Q1 2026 Earnings Call
Thu, May 07, 2026 · 4:30 PM ET
Watch TranscriptInmune Bio (NASDAQ:INMB) Q4 2025 Earnings Call
Mon, Mar 30, 2026 · 4:30 PM ET
Watch Transcript
Latest news
INmune Bio, Inc. Announces Pricing of $4.50 Million Registered Direct Offering and Concurrent Private Placement
Oct 28, 2026
Closed $1.53 (+0.7%) on Oct 28, 2026
INmune Bio Advances Ebstrocel™ Toward Potential UK Approval in Mid-2027
Oct 21, 2026
Closed $1.61 (+0.6%) on Oct 21, 2026
INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar
Oct 21, 2026
Closed $1.61 (+0.6%) on Oct 21, 2026
INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro ™
Oct 14, 2026
Closed $1.60 (-4.8%) on Oct 14, 2026
INmune Bio to Attend the 2026 Maxim Growth Summit
Oct 6, 2026
Closed $1.87 (-3.6%) on Oct 6, 2026
INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board
Sep 14, 2026
Closed $2.33 (+5.0%) on Sep 14, 2026
INmune Bio to Present at the H.C. Wainwright Global Investment Conference
Sep 9, 2026
Closed $2.46 (-2.0%) on Sep 9, 2026
INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings
Aug 26, 2026
Closed $2.45 (+0.6%) on Aug 26, 2026
INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress
Aug 6, 2026
Closed $2.09 (+9.2%) on Aug 7, 2026
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
Jul 31, 2026
Closed $1.75 (-1.1%) on Jul 31, 2026
Financings
Registered direct offering of shares of common stock and concurrent private placement of unregistered warrants
Oct 28, 2026
Announced: about US$4.5M · ½ warrant at US$1.65 for 66 months · A.G.P./Alliance Global Partners
Dealers: A.G.P./Alliance Global Partners (lead)
Use of proceeds: Working capital and general corporate purposes
Decks
Investor Presentation (October 2026)
Investor deck · 53 slides · Oct 21, 2026
Investor Presentation (July 2026)
Investor deck · 59 slides · July 2026
Q4 2025 Earnings Presentation
Earnings · 41 slides · Mar 30, 2026
Investor Presentation (March 2026)
Investor deck · 58 slides · March 2026
INmune Bio Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 39 in the last 12 months · 205 in all · newest Oct 28, 2026 · oldest 2019
- Calls
- 21 calls with a replay · 21 with a transcript · latest Aug 6, 2026
- Decks
- 42 decks · latest Oct 21, 2026
Where INmune Bio Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:INMB · Home listing | NASDAQ | United States | USD |
| BOATS:INMB | BOATS | United States | USD |
| Lang & Schwarz:A2PCBU · This page | Lang & Schwarz | Germany | EUR |
| Tradegate:0Y2 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about INmune Bio Inc.